The developmental requirements for immunological memory, a central feature of adaptive immune responses, is largely obscure. We show that as naive CD8 T cells undergo homeostasis-driven proliferation in lymphopenic mice in the absence of overt antigenic stimulation, they progressively acquire phenotypic and functional characteristics of antigen-induced memory CD8 T cells. Thus, the homeostasis-induced memory CD8 T cells express typical memory cell markers, lyse target cells directly in vitro and in vivo, respond to lower doses of antigen than naive cells, and secrete interferon γ faster upon restimulation. Like antigen-induced memory T cell differentiation, the homeostasis-driven process requires T cell proliferation and, initially, the presence of appropriate restricting major histocompatibility complexes, but it differs by occurring without effector cell formation and without requiring interleukin 2 or costimulation via CD28. These findings define repetitive cell division plus T cell receptor ligation as the basic requirements for naive to memory T cell differentiation.
To determine how murine memory and naive T cells differ, we generated large numbers of long-lived memory CD8؉ T cells and compared them to naive cells expressing the same antigen-specific receptor (T cell receptor; TCR). Although both populations expressed similar levels of TCR and CD8, on antigen stimulation in vitro memory T cells down-regulated their TCR faster and more extensively and secreted IFN-␥ and IL-2 faster than naive T cells. Memory cells were also larger, and when freshly isolated from mice they contained perforin and killed target cells without having to be restimulated. They further differed from naive cells in requiring IL-15 for proliferation and in having a greater tendency to undergo apoptosis in vitro. On antigen stimulation in vivo, however, they proliferated more rapidly than naive cells. These findings suggest that, unlike naive T cells, CD8 memory T cells are intrinsically programmed to rapidly express their effector functions in vivo without having to undergo clonal expansion and differentiation.Following an initial response to antigen, some lymphocytes acquire altered properties and persist for prolonged periods. The collective behavior of these cells, termed immunologic memory, constitutes one of the cardinal features of the vertebrate adaptive immune system (reviewed in refs. 1-3). For B lymphocytes the distinguishing properties between the cells responsible for memory (memory B cells) and their precursors (naive B cells) have long been known (4, 5). In response to antigenic stimulation, memory B cells secrete high-affinity IgG (or IgE or IgA) rather than the low-affinity Abs (IgM and IgG) produced during the primary B cell response (6). These differences result from Ig gene class switching, somatic hypermutation of Ig variable gene segments, and selection of B cells expressing high-affinity Ig receptors by antigen during the primary response to antigen (7-9). The antigen-stimulated generation of memory B cells is largely responsible for the effectiveness of natural infection and vaccines in conferring immunity against many microbial pathogens.Although memory T cells are known to exist (10-20), the properties that distinguish them from their naive precursors are only known to a limited extent. A major obstacle preventing a more complete characterization of memory T cells has been their limited availability and the heterogeneity of the memory T cells expressing different T cell receptors (TCRs) in most model systems. In this study we modified an adoptive transfer protocol (21) by using recombination activating gene-1 (RAG1)-deficient mice as transfer recipients. Because they lack endogenous lymphocytes, a substantial number of memory T cells (3-4 ϫ 10 6 ͞mouse) were generated after adoptive transfer of CD8 TCR transgenic T cells followed by immunization with antigenic peptide. Functional comparisons of the resulting CD8 memory T cells with their naive counterparts revealed some unique properties that may underlie the characteristic memory T cell response. ) mice, backcrossed t...
Factors that affect naïve T cell proliferation in syngeneic lymphopenic hosts were investigated. 2C T cell receptor (TCR) transgenic T cells lacking both CD8 and CD4 survived but hardly proliferated. Proliferation of CD8 ؉ 2C cells was proportional to the abundance of cognate peptide͞MHC complexes and was severely inhibited by injection of anti-CD8 antibody. Weakly reactive selfpeptides slightly enhanced CD8 ؉ 2C cell proliferation whereas a potent agonist peptide promoted much more rapid proliferation, but inflammation-stimulating adjuvant had only a small effect on the rate of cell proliferation. The findings suggest that under uniform lymphopenic conditions, the widely different rates of proliferation of T cells expressing various TCR, or the same TCR in the presence or absence of CD8, reflect the strength of interaction between TCR and MHC associated with particular self-peptides.
A 65 kDa mycobacterial heat shock protein (hsp65), fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist for a particular T cell receptor (2C TCR), stimulated C57BL/6 mice as well as CD4-deficient mice to produce CD8+ cytolytic T lymphocytes (CTL) to the fusion partner's octapeptide. This and other hsp65 fusion proteins but not native hsp65 itself stimulated dendritic cells in vitro and in vivo to upregulate the levels of MHC (class I and II) and costimulatory (B7.2) molecules. The results suggest a mechanism for the general finding that hsp fusion proteins, having fusion partners of widely differing lengths and sequences, elicit CD8 CTL to peptides from the fusion partners without requiring exogenous adjuvants or the participation of CD4+ T cells.
T cells are activated by binding of the T cell receptor (TCR) to a peptide-major histocompatibility complex (MHC) complex (pMHC) expressed on the surface of antigen presenting cells. Various models have predicted that activation is limited to a narrow window of affinities (or dissociation rates) for the TCR–pMHC interaction and that above or below this window, T cells will fail to undergo activation. However, to date there have not been TCRs with sufficiently high affinities in order to test this hypothesis. In this report we examined the activity of a CD8-negative T cell line transfected with a high affinity mutant TCR (KD = 10 nM) derived from cytotoxic T lymphocyte clone 2C by in vitro engineering. The results show that despite a 300-fold higher affinity and a 45-fold longer off-rate compared with the wild-type TCR, T cells that expressed the mutant TCRs were activated by peptide. In fact, activation could be detected at significantly lower peptide concentrations than with T cells that expressed the wild-type TCR. Furthermore, binding and functional analyses of a panel of peptide variants suggested that pMHC stability could account for apparent discrepancies between TCR affinity and T cell activity observed in several prior studies.
CD8 ؉ and CD8 ؊ T cell lines expressing the same antigen-specific receptor [the 2C T cell receptor (TCR)] were compared for ability to bind soluble peptide-MHC and to lyse target cells. The 2C TCR on CD8 ؊ cells bound a syngeneic MHC (K b؉ )-peptide complex 10 -100 times less well than the same TCR on CD8 ؉ cells, and the CD8 ؊ 2C cells lysed target cells presenting this complex very poorly. Surprisingly, however, the CD8 ؊ cells differed little from CD8 ؉ cells in ability to bind an allogeneic MHC (L d؉ )-peptide complex and to lyse target cells presenting this complex. The CD8 ؉ ͞CD8 ؊ difference provided an opportunity to estimate how long TCR engagements with peptide-MHC have to persist to initiate the cytolytic T cell response.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.